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Figure 1. Sox-based chemosensors. a) The ERK1/2 probe utilizes 
the PNT domain from Ets-1 for specific binding to the enzyme and 
senses phosphorylation via Sox-dependent CHEF (λex = 360 nm, 
λem = 485 nm). b) The Sox-PNT sensor is synthesized via NCL. 
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Protein kinases are important regulators of cellular function, and the 
dynamics of their activities are critical indicators of the health or 
pathology of living systems.[1, 2] In particular, extracellular-signal 
regulated kinases 1 and 2 (ERK1/2) play a pivotal role in the 
mitogen-activated protein kinase (MAPK) signaling pathway 
responsible for regulated cell survival and proliferation.[3] The 
centrality of these enzymes in normal and diseased cell states 
underscores the need for high throughput, selective, and sensitive 
methods that accurately and directly diagnose kinase activities. The 
benchmark phosphorylation assays for ERK1/2 rely on transfer of 
radioactive γ-phosphate of [γ-32P]ATP to peptide or protein 
substrates.[4] While broadly employed, this approach has limitations, 
including the discontinuous nature of the radioactive assay and the 
non-native ATP concentrations that are utilized. Alternatively, for 
cellular imaging, genetically-encoded sensors that rely on 
phosphorylation-based changes in fluorescence resonance energy 
transfer (FRET) between fluorescent protein pairs[5, 6] have been 
constructed for several kinases, including ERK1/2.[7-10] These 
sensors are powerful because they can be expressed in cells, 
however, they cannot be used for high throuput screening of 
recombinant enzymes and unfractionated cell lysates due to the very 
limited fluorescence changes that accompany phosphorylation. As a 
complementary approach, probes based on small, organic 
fluorophores with direct readouts[6, 11] can give sensitive and robust 
signals under physiogical conditions and are thus amenable to high 
throughput applications. For example, we have incorporated a 
sulfonamido-oxine (Sox) chromophore into peptides[12, 13] to report 
phosphorylation via chelation-enhanced fluorescence (CHEF) 
(Figure 1a). The weak binding affinity of the unphosphorylated 
substrate for Mg2+ increases significantly upon phosphorylation, 
resulting in robust (2- to 12-fold) fluorescence enhancements. This 
versatile peptide-based sensor design has been applied to monitor 
the activity of numerous Ser/Thr and Tyr kinases both in vitro[13] 
and in cell lysates.[12] 
With more than 500 different kinases encoded in the human 
genome, sensor selectivity becomes paramount, particularly when 
studying enzymes under conditions that resemble their native 
environments, such as in unfractionated cell lysates or live cells.[6] 
While many protein kinases exploit linear recognition motifs 
comprising 4-8 residues that are proximal to the phosphorylation 
site to drive specificity, a number of physiologically important 
kinases, including ERK1/2 and other MAPKs, phosphorylate 
substrates with short and ubiquitous consensus sequences. For these 
enzymes specificity is derived from extended recognition elements 
that include protein-protein interactions distal to the phosphorylation 
site. For example, ERK1 and 2 phosphorylate the transcription 
factor Ets-1 at Thr38 within a short ThrPro (TP) consensus motif.[14] 
Since this short sequence would be the target of multiple kinases, 
ERK recognition of Ets-1 depends an adjoining N-terminal pointed 
(PNT) domain[15] to dock the substrate specifically to ERK1/2, 
which engages the phosphorylation machinery.[16] With this 
docking-domain strategy, PNT-based substrates demonstrate good 
affinity for ERK1/2 (KM ~ 6-9 µM),[15] in stark contrast to short 
peptide substrates derived only from the TP sequence (KM > 200 
µM).[15, 17] Due to the size of the PNT domain (11 kDa) these 
docking-domain interactions cannot be exploited with the types of 
synthetic peptide-based sensors that have been previously reported. 
However, in light of its importance in cellular homeostasis and the 
prominence of ERK disregulation in cancer, we set out to construct 
a chimeric sensor for ERK1/2 that combines the advantageous 
reporting properties of the Sox fluorophore with the outstanding 
specificity provided by the native protein domain-based recognition 
(Figure 1a). Most importantly, to ensure facile and high throughput 
analysis of ERK1/2 activity, our ultimate requirement is that the 
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probe be highly selective in cell lysates where it would be exposed 
to hundreds of other active kinases. 
Herein we describe the semisynthesis of a chimeric Sox-based 
ERK1/2 sensor through a key native chemical ligation (NCL) 
reaction that efficiently conjugates the recombinat PNT domain of 
Ets-1 to a synthetic ERK1/2 consensus sequence including the Sox 
sensing module. The extended PNT recognition element confers the 
ERK1/2 sensor with excellent selectivity, as demonstrated by 
comparative quantitative analyses with a panel of related 
recombinant enzymes and in unfractionated lysates from four 
different cell lines. Most importantly, the docking domain-based 
sensor design should be generally applicable to the development of 
selective sensors for other medically important kinases.  
The new sensor was assembled as illustrated in Figure 1, using 
NCL[18] to ligate the synthetic Sox-containing peptide thioester with 
the expressed PNT domain, comprising Ets-1 residues 46-138 
(Figure 1b). The peptide thioester was synthesized using Fmoc-
based solid phase peptide synthesis (SPPS) on highly acid-labile 
TGT resin, followed by an off-bead thioesterification of the 
protected peptide.[19] The Sox chromophore was introduced as the 
amino acid C-Sox.[13] An optimized phosphorylation motif based on 
the ERK2 phosphorylation sequence within the myelin basic protein 
(MBP)[17] (TPGGRR) was used in place of the phosphorylated 
region of Ets-1 (TPSSKE) to improve fluorescent properties of 
peptidyl probes (Table S1 in the Supporting Information). The 
distance between the TP recognition sequon and the PNT domain in 
the wild type protein was preserved in the sensor (Table S2 in the 
Supporting Information). This design introduced residue 
replacements in the unstructured N-terminal region of Ets-1, thereby 
minimizing perturbations to the overall secondary structure. 
Additionally, the C-terminal residue, Met44, was changed to Gly to 
eliminate the possibility of epimerization during thioesterification 
and to increase ligation efficiency.[20] The expressed C-terminal 
fragment of the sensor, GST-PNT, was proteolyzed to reveal Cys-
PNT. After ligation of Cys-PNT to the peptide thioester in non-
denaturing conditions, the ERK1/2 probe, Sox-PNT, was obtained 
with excellent conversion (80-90%) (Figure S1 in the Supporting 
Information). The corresponding phosphoprotein (pThr38), pSox-
PNT, was constructed using analogous methods. 
Initial spectroscopic studies with Sox-PNT and pSox-PNT 
revealed a robust 3-fold enhancement in fluorescence upon 
phosphorylation (Figure S2 in the Supporting Information). 
Subsequent in vitro assays determined Sox-PNT to be an efficient 
substrate for ERK2 when compared with the corresponding Sox-
peptide (Ac-VP-CSox-LTPGGRRG-OH) (Figure 2a and Figure S3 
in the Supporting Information). Furthermore, Sox-PNT 
demonstrated a KM of 14.9 µM for ERK2, which is comparable to 
the reported value for wild type PNT (9 µM),[21] indicating that use 
of the MBP-derived TP sequence has minimal effect relative to the 
native protein (Figure 2b). In contrast, the MBPtide (APRTPGGRR), 
the basis of the Sox-PNT phosphorylation sequence, was reported to 
have a KM of 2 mM for ERK2, underscoring the importance of the 
PNT domain in substrate kinetics.[17] Finally, Sox-PNT exhibited 
high selectivity for ERK1/2 when compared to related kinases from 
the JNK, p38 and CDK families (Figure 2c).  
In order to demonstrate that the preference of Sox-PNT for 
ERK1/2 can translate to complex media, the probe was exposed to a 
panel of unfractionated cell lysates that contained varying levels of 
active ERK1/2. The activity of cellular ERK1/2 is linked to its 
phosphorylation state, which is modulated by the epidermal growth 
factor (EGF) signaling pathway (Figure 3a). In summary, EGF 
interacts with EGF receptors (EGFRs), which leads to activation of 
MEK1/2, which in turn phosphorylates and activates ERK1/2. This 
event can be regulated either by the upstream MEK1/2 inhibitor, 
U0126, or by a direct ERK1/2 inhibitor, PEA-15.[22] Summarized in 
Figure 3b are the results of ERK1/2 activity analyses on the crude 
lysates from four mammalian cell lines, which reveal the selectivity 
of the sensor in these complex media. In all cases, untreated lysates 
showed relatively low basal activity. Upon EGF stimulation, there 
was a 4- to 10-fold increase in activity.[23] To demonstrate that Sox-
PNT was specifically monitoring ERK1/2 activity, cells were 
exposed to the inhibitor U0126 and subsequently EGF-stimulated 
and lysed. Under these conditions, the ERK1/2 activity was returned 
to nearly basal levels. Western blot analysis was used to 
demonstrate that both stimulated and U0126 inhibitor-treated cells 
expressed ERK1/2 (Figure 3b), however, only EGF-stimulated 
samples showed enhanced levels of activated ERK1/2 as evidenced 
by analysis with the phopho-ERK1/2-specific antibody. In contrast, 
the Sox-peptide, lacking the PNT docking domain, showed 
promiscuous activity and signaled phosphorylation that could not be 
correlated with ERK1/2 activity (Figure 3c). 
 
 
 
Figure 2. In vitro characterization of Sox-PNT. a) The efficiency of 
phsophorylation by recombinant ERK2 (11 ng) of the Sox-PNT probe 
was compared to that of the Sox-peptide under identical conditions. b) 
The kinetic parameters for Sox-PNT were obtained with ERK2 (10 ng) 
from a direct fit of ν vs. [S] plots using the Briggs-Haldane equation. 
Plotted values indicate the mean ± s.e.m. for triplicate measurements. 
c) Promiscuity of Sox-PNT (5 µM) was tested with a panel of related 
kinases at 15 nM (black bars) and 150 nM (clear bars) of each 
enzyme. Inset: a representative plot of the change in the fluorescent 
signal over time obtained with 15 nM enzyme in the fluorescence 
plate reader. Plotted values for 15 nM of enzyme indicate the mean ± 
s.e.m. for triplicate measurements. 
 
Further evidence that Sox-PNT is selectively modified by 
ERK1/2 was obtained with PEA-15, a direct protein inhibitor of 
ERK1/2. Titration of PEA-15 into EGF-stimulated NIH-3T3 lysates 
created a dose-dependent response with a half inhibitory 
concentration of 40 nM and a Ki (30 nM) that reflected the reported 
Ki values (20 nM) (Figure 3d and the Supporting Information).[22]  
To directly correlate the observed fluorescent signal to the 
presence of ERK, we exposed our probe to ERK1/2-depleted lysates. 
Indeed, immunodepletion of ERK1/2 from EGF-stimulated HeLa 
lysate reduced activity by 7-fold compared to the input lysate or the 
sample that had been depleted with naïve rabbit IgG (Figure 3e). 
This indicates that the Sox-PNT signal is predominantly due to the 
ERK1/2-mediated phosphorylation. Immunodepletion was 
confirmed by western blot analysis with the immunodepleting 
antibody (Figure 3e, inset). Having validated the selectivity of Sox-
PNT for ERK1/2, the sensor can be used to measure active ERK1/2 
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Figure 3. Specificity of the Sox-PNT sensor toward ERK1/2 in unfractionated cell lysates. a) The EGF 
signalling pathway results in stimulation of ERK1/2 activity. U0126, an inhibitor of an upstream kinase, 
MEK1/2, and PEA-15, a direct inhibitor of ERK1/2 can regulate the activity of ERK1/2. b) Sox-PNT (5 µM) was 
used to measure enzyme activity in 40 µg of untreated lysates (red bars), EGF-stimulated lysates (blue bars), 
or U0126-treated and then EGF-stimulated lysates (black bars). Inset: western blot for pERK1/2 (top) and 
ERK1/2 (bottom). c) The ability of Sox-PNT (black bars, 5 µM) to report the different phosphorylation states of 
ERK1/2 in HeLa lysates (40 µg) was directly compared to the Sox-peptide (clear bars, 5 µM). d) To obtain the 
IC50 value for inhibition of ERK1/2 by PEA-15, EGF-stimulated NIH-3T3 lysates (40 µg) were treated with 
various concentrations of PEA-15 and enzyme activity was measured with Sox-PNT (5 µM). e) Kinase activity 
was measured with Sox-PNT (5 µM) from an EGF-stimulated HeLa lysate (40 µg) before (input) and after 
immunodepletion of this lysate with anti-ERK1/2 or naïve rabbit IgG. Inset: western blot for ERK1/2 in the 
measured samples. The top band in all western blots is ERK1 (44 kDa) and the bottom band ERK2 (42 kDa). 
Plotted values indicate the mean ± s.e.m. for triplicate measurements. 
(13 ng) in EGF-stimulated 
lysate (40 µg) (Figure S5 in 
the Supporting 
Information), which will be 
an important tool for 
quantifying ERK1/2 levels 
in tissue samples. 
The MAPK signaling 
pathways are composed of 
numerous kinases 
intricately regulated by 
stress responses and 
extracellular signals. 
Deconvoluting the specific 
functions of individual 
enzymes has been 
challenging, partly due to 
the difficulty of creating 
probes that exclusively 
target a kinase of interest. 
Here we have presented a 
selective ERK1/2 activity 
chemosensor that 
comprises both a chemical 
sensing motif and 
recombinant enzyme 
docking domain. Thereby, 
the Sox-based kinase-
sensing strategy has been 
extended beyond the realm 
of enzymes that recognize 
linear peptide substrates. 
Quantitative studies with 
the probe indicate that the 
PNT domain confers 
exquisite selectivity toward 
ERK1/2, which was 
impossible to achieve with 
simple peptide probes. 
Moreover, the docking-
domain approach now 
allows us to target a wider 
set of kinases (such as 
other members of the 
MAPK family, JNK and p38) that have thus far been elusive due to 
their complex substrate recognition mechanisms. The chimeric 
protein probe also offers distinct advantages for solution-based 
analyses that can be carried out with simple equipment. The reliable 
semisynthesis of multimilligram (6 mg) quantities of Sox-PNT 
allows at least 5000 assays to be performed in 384-well plates. 
Moreover, Sox-based sensors exhibit large dynamic ranges with 
excellent Z‘ factor values,[13] which are a measure of the fidelity of 
assay data.[24] Currently, in light of the efficient semisynthesis, 
excellent selectivity and robustness in high throughput analysis, the 
Sox-PNT sensor can be broadly applied for quantifying ERK1/2 
activities in applications ranging from drug discovery to diagnostics. 
 
Received: ((will be filled in by the editorial staff)) 
Published online on ((will be filled in by the editorial staff)) 
Keywords: Protein Kinase Sensors · Native Chemical Ligation · 
ERK1/2 · Lysate Assays · Phosphorylation 
 
[1] G. Manning, D. B. Whyte, R. Martinez, T. Hunter, S. Sudarsanam, 
Science 2002, 298, 1912-1934. 
[2] T. Hunter, Cell 2000, 100, 113-127. 
[3] P. P. Roux, J. Blenis, Microbiol. Mol. Biol. Rev. 2004, 68, 320-344. 
[4] K. A. Janes, J. G. Albeck, L. X. Peng, P. K. Sorger, D. A. 
Lauffenburger, M. B. Yaffe, Mol. Cell. Proteomics 2003, 2, 463-473. 
[5] Q. Ni, D. V. Titov, J. Zhang, Methods 2006, 40, 279-286. 
[6] D. M. Rothman, M. D. Shults, B. Imperiali, Trends Cell Biol. 2005, 
15, 502-510. 
[7] H. M. Green, J. Alberola-Ila, BMC Chem. Biol. 2005, 5, 1. 
[8] A. Fujioka, K. Terai, R. E. Itoh, K. Aoki, T. Nakamura, S. Kuroda, E. 
Nishida, M. Matsuda, J. Biol. Chem. 2006, 281, 8917-8926. 
[9] M. Sato, Y. Kawai, Y. Umezawa, Anal. Chem. 2007, 79, 2570-2575. 
[10] C. D. Harvey, A. G. Ehrhardt, C. Cellurale, H. Zhong, R. Yasuda, R. J. 
Davis, K. Svoboda, Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 19264-
19269. 
[11] V. Sharma, Q. Wang, D. S. Lawrence, Biochim. Biophys. Acta 2008, 
1784, 94-99. 
[12] M. D. Shults, K. A. Janes, D. A. Lauffenburger, B. Imperiali, Nat. 
Methods 2005, 2, 277-283. 
[13] E. Lukovic, J. A. Gonzalez-Vera, B. Imperiali, J. Am. Chem. Soc. 
2008, 130, 12821-12827. 
 4 
[14] C. E. Foulds, M. L. Nelson, A. G. Blaszczak, B. J. Graves, Mol. Cell. 
Biol. 2004, 24, 10954-10964. 
[15] J. J. Seidel, B. J. Graves, Genes Dev. 2002, 16, 127-137. 
[16] M. A. Rainey, K. Callaway, R. Barnes, B. Wilson, K. N. Dalby, J. Am. 
Chem. Soc. 2005, 127, 10494-10495. 
[17] J. W. Haycock, J. Neurosci. Meth. 2002, 116, 29-34. 
[18] P. E. Dawson, T. W. Muir, I. Clark-Lewis, S. B. H. Kent, Science 
1994, 266, 776-779. 
[19] E. M. Vogel, B. Imperiali, Protein Sci. 2007, 16, 550-556. 
[20] T. M. Hackeng, J. H. Griffin, P. E. Dawson, Proc. Natl. Acad. Sci. 
U.S.A. 1999, 96, 10068-10073. 
[21] O. Abramczyk, M. A. Rainey, R. Barnes, L. Martin, K. N. Dalby, 
Biochemistry 2007, 46, 9174-9186. 
[22] K. Callaway, O. Abramczyk, L. Martin, K. N. Dalby, Biochemistry 
2007, 46, 9187-9198. 
[23] A. R. Asthagiri, A. F. Horwitz, D. A. Lauffenburger, Anal. Biochem. 
1999, 269, 342-347. 
[24] J. H. Zhang, T. D. Chung, K. R. Oldenburg, J. Biomol. Screen. 1999, 
4, 67-73. 
 
 
 
 
 
 
 
 5 
Entry for the Table of Contents (Please choose one layout) 
 
Layout 1: 
Bioorganic Sensors 
 
The best of both worlds: By combining 
a recombinant docking domain, PNT, 
with a chemical sensing module, Sox, a 
highly selective ERK kinase sensor was 
synthesized. This probe displays 
excellent in vitro characteristics and, 
moreover, can be used to exclusively 
monitor ERK1/2 activity in 
unfractionated cell lysates without any 
off-target kinase inhibitors. Strong 
selectivity and robust biophysical 
parameters allow ERK1/2 activity to be 
analyzed in a high throughput manner, 
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I. General information 
 
Unless otherwise noted, all solvents and reagents were obtained commercially and used without 
further purification. Nα-Fmoc-protected amino acids [Fmoc-Arg(Pbf)-OH, Fmoc-Gly-OH, 
Fmoc-Leu-OH, Fmoc-Pro-OH, Fmoc-Thr(tBu)-OH, Fmoc-Thr(PO(OBn)OH)-OH, Fmoc-Val-
OH]§
II. Instrumentation 
 were purchased from Novabiochem. Fmoc-C(Sox[TBDPS])-OH was synthesized 
according to published procedures.1 Anhydrous CH2Cl2 was distilled from calcium hydride. 
Doubly deionized water was degassed by bubbling argon for 20 min at room temperature. 
Organic solutions were concentrated in vacuo by rotary evaporation at ~10 Torr (house vacuum) 
at 25-40 oC, then at ~0.5 Torr (vacuum pump), unless otherwise indicated. Peptides were purified 
via preparative reverse-phase HPLC employing a gradient of solvents A (H2O with 0.1% v/v 
TFA) and B (CH3CN with 0.1% v/v TFA). Peptide purity was determined by analytical reverse-
phase HPLC. FPLC protein purification was done in 20 mM Tris (pH 8.0 at 25 oC) and 200 mM 
NaCl. Protein purity was confirmed by SDS-PAGE with Coomassie blue staining or by western 
blots visualized using appropriate antibodies. 
 
 
HPLC: HPLC was carried out on Waters Prep LC 4000 System or Waters Delta 600 System 
equipped with Waters 2487 dual wavelength absorbance detectors. Columns used: C18 analytical 
(flow rate = 1 mL/min), Beckman Ultrasphere ODS, 5 µm, 150 x 4.6 mm; C18 preparatory (flow 
rate = 15 mL/min), YMC-Pack Pro, 5 µm, 250 x 20 mm. 
 
FPLC: FPLC was carried out on Pharmacia Biotech system equipped with Pharmacia Biotech 
UV-MII absorbance detector and Pump P-500. Columns used: Pharmacia Biotech SuperdexTM 
75 analytical; Pharmacia Biotech HiLoadTM 16/60 SuperdexTM 75 prep grade. Flow rate = 1 
mL/min for both. 
 
ESI-MS: Applied Biosystems Mariner mass spectrometer. 
 
MALDI-TOF MS: PerSeptive Biosystems Voyager MALDI-TOF instrument. 
                                                 
§ Abbreviations: ATP: adenosine triphosphate, BME: β-mercaptoethanol, Bn: benzyl, tBu: t-butyl, Boc: t-
butoxycarbonyl, BSA: bovine serum albumin, CDK: cyclin-dependent kinase, DIEA: diisopropylethylamine, 
DMEM: Dulbecco’s Modified Eagle Medium, DMF: N,N-dimethylformamide, DMSO: dimethyl sulfoxide, DTT: 
dithiothreitol, EDTA: ethylenediaminetetraacetic acid, EGTA: glycol-bis(2-aminoethylether)-N,N,N’,N’-tetraacetic 
acid, ERK1/2: extracellular signal-regulated kinase 1/2, ESI-MS: Electrospray Ionization Mass Spectrometry, Fmoc: 
9-fluorenylmethoxycarbonyl, FPLC: fast protein liquid chormatography, FPR: fluorescence plate reader, HEPES: 4-
(2-hydroxyethyl)-1-piperazine ethane sulfonic acid, HOAt: 7-aza-1-hydroxybenzotriazole, HOBt: 1-
hydroxybenzotriazole, HPLC: high performance liquid chromatography, JNK: c-Jun N-terminal kinase, MALDI-
TOF MS: Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry, Pbf: 2,2,4,6,7-
pentamethyldihydrobenzofuran-5-sulfonyl, PyAOP: (7-azabenzotriazol-1-yloxy)tripyrrolidinophosphonium 
hexafluorophosphate, PyBOP: Benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate, SDS-PAGE: 
sodium dodecyl sulfate polyacrylamide gel electrophoresis, SPPS: solid-phase peptide synthesis, TBDPS: t-
butyldiphenylsilyl, TFA: trifluoroacetic acid, TIS: triisopropylsilane, TNBS: 2,4,6-trinitrobenzene sulfonic acid, 
Tris: 2-amino-2-hydroxymethyl-propane-1,3-diol, UV: Ultraviolet. 
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UV-Vis Spectrophotometer: Shimadzu UV-2401PC. 
 
Fluorometer: Fluoromax 3 from Jobin Yvon. Cuvette: Starna Cells (16.100F-Q-10) 100 µL sub-
micro cuvette, 1 cm path length.  
 
Fluorescence Plate Reader: HTS 7000 Bio Assay Reader from Perkin Elmer. Plate: Corning 
(3992) assay plate, 96-well, half area, no lid, flat bottom, non-binding surface, non-sterile, white 
polystyrene (120 µL reaction volume) or MatriCal (MP101-1-PP) 384-well MatriPlate, 50 µL, 
black polystyrene (20 µL reaction volume). 
 
Chemilluminescence Reader: Bio-Rad with Quantity One 1-D Analysis Software. 
 
III. Stock solutions 
 
Due to the affinity of the phosphorylated probes for Mg2+, by analogy with previously reported 
probes,1,2 the reagents with the highest purity and lowest metal content were used where 
indicated to avoid the necessity of removing metal ion impurities after preparations. 
 
1. Stock solutions of the Sox-containing peptides and proteins were prepared in doubly deionized 
water (Sox-peptides) or TBS (solution 7 for Sox-PNT), and concentrations were determined by 
UV-Vis (based on the determined extinction coefficient of the fluorophore unit, 5-(N,N-
dimethylsulfonamido)-8-hydroxy-2-methylquinoline, ε355 = 8247 M-1 cm-1 at 355 nm in 0.1 M 
NaOH with 1 mM Na2EDTA). An average of the values from three separate solutions, each 
prepared using a different volume of the stock solution, was read on UV-Vis spectrophotometer. 
Purified peptide stock solutions can be stored at 4 °C for at least 6 months or -20 oC for longer 
periods. Protein stock solutions were flash-frozen and stored at -80 oC. 
 
2. Magnesium chloride stock solution was prepared from Alfa Aesar's Puratronic grade salt and 
stored at room temperature. Most commercially available salts contain Zn2+ as significant 
impurities and should not be used due to the high affinity of the phosphorylated peptides for 
Zn2+. The Mg2+ concentration was determined by titration with a standardized solution of EDTA 
(Aldrich) in the presence of an Eriochrome Black T (Aldrich) as described previously.2 
 
3. 500 mM HEPES (SigmaUltra) was prepared and adjusted to pH 7.4 with NaOH (99.998+%, 
Aldrich) solution and stored at 4 oC.  
 
4. 1 M Tris (Calbiochem, ULTROL grade) was prepared and adjusted to pH 7.5 with NaOH 
(99.998+%, Aldrich) solution and stored at 4 oC. 
 
5. 2 M NaCl (SigmaUltra) was prepared in doubly deionized water and stored at room 
temperature. 
 
6. 500 mM and 10 mM dithiothreitol (DTT, Biotechnology grade, Mallinckrodt) solutions were 
prepared in degassed doubly deionized water and stored at -80 oC.  
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7. 10x TBS Buffer (200 mM Tris-HCl [pH 8 at 4 oC], 2 M NaCl) was prepared from Tris-HCl 
(Calbiochem, ULTROL grade, 15.76 g for 1 L solution) and NaCl (SigmaUltra, 58.453 g for 1 L 
solution) and adjusted to pH 8 at 4 oC with NaOH (99.998+%, Aldrich) solution.  
 
8. 20 mg/mL BSA (Heat Shock Fraction V, Roche) was prepared in ultrapure water, filtered 
through a 0.45 micron syringe filter to remove particulates and stored at 4 oC. 
 
9. 0.1% Brij-35 P (Fluka) was prepared in doubly deionized water and stored at room 
temperature. 
 
10. 20% Triton X-100 (SigmaUltra) was prepared in doubly deionized water and stored at 4 oC. 
 
11. 100 mM ATP (Disodium salt, Low Metals Grade, Calbiochem) was prepared in ultrapure 
water and stored in aliquots at -80 oC. 
 
12. 500 mM EGTA was prepared from ethylene glycol-bis(2-aminoehtylether)-N,N,N’,N’-
tetraacetic acid (SigmaUltra) dissolved in 2 M NaOH and stored at 4 oC.  
 
13. 10x Assay Buffer I: 500 mM Tris-HCl (pH 7.5 at 25 oC), 100 mM MgCl2, 10 mM EGTA, 20 
mM DTT and 0.1% Triton X-100.  
 
14. 10x Assay Buffer II: 500 mM Tris-HCl (pH 7.5 at 25 oC), 100 mM MgCl2, 10 mM EGTA, 
20 mM DTT and 0.1% Brij 35 P. 
 
15. Lysis Buffer I: PBS, 1 mg/mL lysozyme, 1 mM DTT, 1% NP-40 Alternative and protease 
inhibitor cocktail III (Calbiochem: 100 µM AEBSF, 80 nM aprotinin, 5 µM bestatin, 1.5 µM E-
64, 2 µM leupeptin, 1 µM pepstatin A). 
 
16. Lysis Buffer II: 50 mM Tris (pH 7.5 at 25 oC), 150 mM NaCl, 50 mM β-glycerophosphate 
(pH 7.3), 10 mM sodium pyrophosphate, 30 mM NaF, 1% Triton X-100, 1 mM benzamidine, 2 
mM EGTA, 100 µM Na3VO4, 1 mM DTT, protease inhibitor cocktail III (10 µL/mL, 
Calbiochem: 10 mM AEBSF, 8 µM aprotinin, 0.5 mM bestatin, 0.15 mM E-64, 0.2 mM 
leupeptin, 0.1 mM pepstatin A), and phosphatase inhibitor cocktail 1 (10 µL/mL, Sigma, P2825). 
The buffer can be stored at -20 oC for up to 3 months; without protease and phosphatase 
inhibitors, it can be stored at -20 oC indefinitely. 
 
17. HeLa Medium: DMEM (Gibco, 11995) supplemented with 10% (v/v) heat-deactivated FBS 
(fetal bovine serum, warmed to 56 oC for 30 min, inverted several times every 10 min), 100 
U/mL penicillin (Gibco, 15140) and 100 µg/mL streptomycin (Gibco, 15140). Serum-free 
medium: DMEM, 2 mM L-Gln (Gibco, 25030), 100 U/mL penicillin and 100 µg/mL 
streptomycin. All cell media were filtered through a 1 L filter flask (0.22 um PES sterilizing low 
protein binding membrane, non-pyrogenic, polystyrene, Corning 431098). 
 
18. NIH-3T3 Medium: DMEM (Gibco, 11995) supplemented with 10% (v/v) FBS, 100 U/mL 
penicillin and 100 µg/mL streptomycin. Serum-free medium: DMEM, 2 mM L-Gln, 100 U/mL 
penicillin and 100 µg/mL streptomycin. 
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19. HT-29 Medium: McCoy’s 5A Medium (Gibco, 1660) supplemented with 10% (v/v) FBS, 2 
mM L-Gln, 100 U/mL penicillin and 100 µg/mL streptomycin. Serum-free medium: McCoy’s 
5A Media, 4 mM L-Gln, 100 U/mL penicillin and 100 µg/mL streptomycin. 
 
20. PtK-1 Medium: Ham’s F-12 Medium (Sigma, N8641) supplemented with 10% (v/v) FBS, 2 
mM L-Gln, 1 mM sodium pyruvate (Gibco, 11360), 100 U/mL penicillin and 100 µg/mL 
streptomycin. Serum-free medium: Ham’s F12 Medium, 4 mM L-Gln, 1 mM sodium pyruvate, 
100 U/mL penicillin and 100 µg/mL streptomycin.  
 
IV. Semisynthesis of (p)Sox-PNT 
 
a. Peptide synthesis 
 
Peptides were synthesized using standard Fmoc amino acid protection chemistry on Fmoc-Gly-
Novasyn-TGT resin (Novabiochem, 0.2 mmol/g). The resin was swelled in CH2Cl2 (5 min.) and 
then DMF (5 min.) prior to synthesis. All the amino acids except for Fmoc-C(Sox[TBDPS])-OH 
were attached according to the following procedure: Fmoc deprotection (20% 4-methylpiperidine 
in DMF, 3 x 5 min.), rinsing step (DMF, 5 x), coupling step (amino acid/PyBOP/HOBt/DIEA, 
6:6:6:6, 0.15 M in DMF, 30-45 min.), rinsing step (DMF, 5 x; DCM, 5 x). Fmoc-
C(Sox[TBDPS])-OH was coupled in the following manner: amino acid/PyAOP/HOAt/2,4,6-
collidine, 2:2:2:5, 0.15 M in DMF, 2-12 hr. The coupling was repeated if necessary (amino 
acid/PyAOP/HOAt/2,4,6-collidine, 1:1:1:3, 0.15 M in DMF, 2-12 hr) as determined by the 
TNBS test for free amines. It is important to wash the resin rigorously (DMF followed by 
CH2Cl2) to remove excess amino acid before performing any tests for free amines. This is 
particularly necessary after coupling of Fmoc-C(Sox[TBDPS])-OH due to its deep red color, 
which does not affect its coupling efficiency. At the end of the synthesis, the Fmoc group was 
removed with 20% 4-methylpiperidine in DMF (3 x 5 min.) and the resin was rinsed with DMF 
(5 x). The resin-attached free amines were capped by exposure to Ac2O (20 equiv.) and pyridine 
(20 equiv.) in DMF for 30 min. The resin was rinsed with DMF (5 x), CH2Cl2 (5 x) and 
subjected to 20% 4-methylpiperidine in DMF (3 x 5 min.) to remove any C-Sox aryl esters that 
might have formed during acetylation. The resin was finally washed with DMF, CH2Cl2, MeOH 
(5 x each) and dried under vacuum.  
 
b. Thioesterification of Sox-containing peptides 
 
Following SPPS the peptide (10 μmol from 50 mg of resin) was cleaved from the resin with side-
chain protection intact by agitating with 0.5% TFA in CH2Cl2 for 1.5 h. The resin was removed 
by filtration and rinsed with CH2Cl2. The solvent was mostly evaporated under a stream of 
nitrogen, and the peptide was triturated with cold hexanes. The hexanes were removed in vacuo, 
and the resulting white powder was dissolved in 16 mL of anhydrous CH2Cl2 and treated with 
HATU (30 mg, 80 µmol) and HOAt (10.8 mg, 80 µmol) dissolved in 0.5 mL dry DMF, followed 
by addition of 2,4,6-collidine (21 µL, 160 µmol) and benzylmercaptan (19 µL, 160 µmol). The 
reaction was stirred under N2 overnight. The solvent was removed in vacuo, and the peptide was 
deprotected with TFA/H2O/TIS (95:2.5:2.5% v/v) for 3 h. The resulting solution was 
concentrated under a stream of N2 and precipitated by addition of cold Et2O. The pellet was 
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triturated with cold Et2O (3 x), redissolved in water, filtered and lyophilized. The peptides were 
purified by preparative reverse-phase HPLC using UV detection at 228 nm (amide bond 
absorption) and 316 nm (C-Sox absorption). Only fractions showing a single peak by analytical 
HPLC and with a correct mass were used in further experiments. 
 
c. Characterization data for peptides 
 
a Peptides were purified according to the following method: 5% B (5 min.) followed by a linear 
gradient 5–95% B (30 min.). b The data was collected on a MALDI-TOF mass spectrometer. 
 
d. Plasmid construction for GST-ENLYFQC-PNT(46-138)-His6 (GST-PNT) 
 
The gene fragment encoding residues 46-138 of Ets-1 (including the PNT domain) was amplified 
from an Ets-1 plasmid using primers to insert 5’ EcoR1 and 3’ Not1 restriction sites for 
incorporation into a pGEX-4T-2 vector. The primers also encoded an amino-terminal TEV 
protease cleavage site (ENLYGQC) and a carboxy-terminal hexahistidine tag.  For this 
amplification the following PCR primers were used:  
 
5’- GCC GGA ATT CGT GAA AAC CTG TAT TTT CAG TGC TCC CAA GCC TTG AAA 
GCT -3’ 
 
3’- GCC CCC TTT TGC GGC CGC CTA GTG ATG GTG ATG GTG ATG ACC TTT CAC 
ATC CTC TTT CTG -5’ 
 
The PCR-amplified fragments were digested with Not1 and EcoR1 and ligated to Not1/EcoR1-
digested and CIP-treated pGEX-4T-2. The ligation mixture was transformed into DH5α cells and 
grown on carbenicillin-resistant plates. Plasmid DNA was isolated from selected colonies and 
confirmed by sequencing. 
 
e. Expression of GST-PNT 
 
The PNT domain plasmid was transformed into BL21(DE3) competent cells (Stratagene) and 
grown at 37 °C to midlog phase in 1 L of LB media with carbenicillin. The culture was cooled to 
30 °C, and the cells were induced with 0.2 mM IPTG and grown for an additional 4.5 h. Cells 
were harvested by centrifugation and frozen at -80 °C. For cell lysis, the pellet from a 1 L 
expression was thawed and resuspended in 40 mL of freshly prepared lysis buffer I and 
incubated for 20 min at 4 °C. The cells were then sonicated and subjected to centrifugation at 
12,429 x g for 25 min, followed by filtration through a 0.2 micron filter.   
 
Name Peptide Sequence Mol. Formula 
HPLC tR 
(min.)a  
[M] 
Calcd. 
[M+H]+ 
foundb 
Sox-peptide Ac-VPC(Sox)LTPGGRRG-CO2H C67H101N19O16S3   25.7 1418.6 1419.3 
Sox-thioester Ac-VPC(Sox)LTPGGRRG-COSBn C64H96N17O16PS 27.2 1523.7 1524.8 
pSox-peptide Ac-VPC(Sox)LpTPGGRRG-CO2H C60H96N19O20PS2  24.4 1498.6 1499.2 
pSox-thioester Ac-VPC(Sox)LpTPGGRRG-COSBn C44H82N17O15PS 27.2 1603.7 1604.9 
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f. Isolation of GST-PNT and on-resin TEV proteolysis to yield Cys-PNT(46-138)-His6 (Cys-PNT) 
 
The filtered supernatant was incubated with 5 mL of Glutathione Sepharose 4 Fast Flow resin 
(Amersham Biosciences) for 1.5 hours at 4 oC, following the manufacturer’s protocol. After 
extensive washes with PBS (20 column volumes) the resin-bound GST-PNT was proteolyzed 
overnight with TEV (prepared in house) in 5 mL of PBS, 5 mM EDTA and 5 mM BME at 25 oC 
with slight agitation. Upon completion of the reaction (ca. 12 hours), the soluble fraction was 
filtered and the resin was washed with PBS (4 x 2 mL). The filtrate and PBS washes were 
combined and concentrated in a swinging bucket centrifuge using 3.5 kDa MWCO Amicon 
Ultra-15 centrifugal filters (Millipore) to give 24 mg of Cys-PNT (MW = 11,672.34 g/mol) as 
determined by Bio-Rad’s Protein Assay. The protein was analyzed by SDS-PAGE and visualized 
with Coomassie blue dye and by western blot with a mouse anti-hexahistidine primary antibody.  
Purified protein was stored at 4 ºC. 
 
g. Native Chemical Ligation to obtain Sox-PNT 
 
To a 2 mL centrifuge tube was added Cys-PNT (21.7 mg, 1.86 µmol, 1 equiv.), followed by 
MESNa and Tris (pH 8.0 at 25 oC) so that the final concentrations were: 1.4 mM Cys-PNT, 150 
mM MESNa and 50 mM Tris in 1.3 mL total reaction volume. Lastly, Sox-thioester (4.2 mg, 
2.79 µmol, 1.5 equiv.) dissolved in 40 µL of water was added and the reaction was gently mixed 
for 24-48 h at 25 oC. The progress of the reaction was analyzed by SDS-PAGE, and visualized 
with Coomassie blue dye (Figure S1).  
 
 
 
Figure S1. Commassie-stained gel of the ligation reaction indicated 80-90% conversion of the 
Cys-PNT expressed segment to the products, Sox-PNT and pSox-PNT. 
 
h. Purification of Sox-PNT 
 
The crude mixture was immediately purified on the FPLC using the Superdex 75 prep column in 
20 mM Tris (pH 8 at 25 oC) and 200 mM NaCl. The protein was analyzed by SDS-PAGE, and 
visualized with Coomassie blue dye. The fractions with the desired product were combined and 
concentrated in a swinging bucket centrifuge using 3.5 kDa MWCO Amicon Ultra-15 centrifugal 
filters. The final concentration of Sox-PNT was determined using the Sox chromophore 
absorbance in the UV-Vis. The overall yield from NCL to final purification of Sox-PNT (6.2 mg, 
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MW = 13,016.73 g/mol) was 24%. The protein was aliquoted, flash-frozen and stored at -80 oC 
where it is stable for at least 1 year. 
 
V. In vitro evaluations of Sox-based probes 
 
a. Ets-1- and MBP-derived peptide probes for ERK1/2 
 
Early peptide probes were based on the β-Turn Focused (BTF) design developed in our lab using 
the Sox amino acid as the sensing moiety.2 Two peptides, one derived from the Ets-1 
phsophorylation sequence (entry 1 in Table S1) and one from the MBP phosphorylation 
sequence (entry 2), were synthesized and their fluorescence difference measured. The main 
differences lie in the underlined region. 
 
In fluorescence increase measurements the concentration of the substrate was held constant while 
the concentration of ATP was varied. No enzyme was present. A solution of the substrate (or 
phosphopeptide) was prepared (20 mM HEPES [pH 7.4], 10 mM MgCl2, 10 µM peptide at 30 
oC), and fluorometer readings were obtained without any ATP present. ATP (stock solution 11) 
was then added to a final concentration of 1 mM. At each ATP concentration a fluorescence 
emission spectrum was recorded (slit widths: Em = 5 nm, Ex = 5 nm; λex = 360 nm, λem = 380-
650 nm). Fluorescence increase was obtained by dividing the fluorescence of the phosphopeptide 
by the fluorescence of the substrate at 485 nm. The values reported are averages of at least three 
separate measurements.  
 
Table S1. Fold fluorescence increase of BTF and RDF chemosensors in the presence and 
absence of ATP 
 
  Fold fluorescence increase 
Entry Peptide Sequence 0 mM ATP 1 mM ATP 
1 H2N-DDK-Sox-PL-(p)T-PSSKEG-CO2H 1.7 1.5 
2 H2N-DDK-Sox-PL-(p)T-PGGRRG-CO2H 2.1 2.3 
3 Ac-VPLL-(p)T-P-CSox-GRRG- CO2H 5.4 5.1 
4 Ac-VPLL-(p)T-PG-CSox-RRG- CO2H 6.3 6.2 
5 Ac-VP-CSox-L-(p)T-PGGRRG- CO2H 6.9 8.1 
 
MBP-based probe offered better fluorescence enhancements than the Ets-1-based sensor. 
Because of these results the eventual Recognition-Domain Focused (RDF) peptides incorporated 
the MBP-derived phosphorylation sequence and the optimal one was ligated to the PNT domain 
of Ets-1. 
 
RDF probes (entries 3-5) incorporate the C-Sox amino acid and generally have significantly 
higher fluorescence increases compared to the BTF probes. The peptide sensor with the highest 
fluorescence increase (entry 5) preserves the entire MBP-based sequence C-terminal to the TP 
recognition site and gives a fluorescence enhancement of ca. 7-fold under these conditions.  
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Table S2. Sequences surrounding the TP recognition region (red residues) of the wild type Ets-1, 
MBP and Sox-PNT. 
     
38 
       
46 
 
138 
Ets-1(32-138) V P L L T P S S K E M M S … K 
MBPtide 
 
A P R T P G G R R 
     Sox-PNT V P C-Sox L T P G G R R G C S … K 
 
The Met44-Met45 site in Ets-1 was changed to Gly44-Cys45 (underlined residues) in Sox-PNT 
due to requirements for NCL.  
  
b. Fluoresence increases of Sox-peptide and Sox-PNT chemosensors 
 
The fluorescence increases of the Sox-peptide (Figure S1a) and Sox-PNT (Figure S1b) were 
measured in the fluorometer (slit widths: Em = 5 nm, Ex = 5 nm; λex = 360 nm, λem = 380-650 
nm) in a quartz microcuvette (total volume of 120 µL) under the following conditions: 10 µM 
unphosphorylated (red) or phosphorylated (black) sample, 50 mM Tris (pH 7.5), 10 mM MgCl2, 
1 mM EGTA, 2 mM DTT and 0.01% Brij 35 P at 30 oC. 
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Figure S2. Fluorescence spectra of phosphorylated (black) and unphosphorylated (red) versions 
of (a) Sox-peptide and (b) Sox-PNT sensors. 
 
While there is a drop in fluorescence enhancement in the Sox-PNT probe, a 3-fold change 
observed with Sox-PNT is still a robust increase for use in vitro, cell lysate and in vivo 
experiments.  
 
c. Affinity of ERK2 for Sox-PNT and Sox-peptide 
 
The activity of recombinant ERK2 (NEB) was measured over time with Sox-PNT and Sox-
peptide in the fluorometer (slit widths: Em = 5 nm, Ex = 5 nm; λex = 360 nm, λem = 485 nm) in a 
quartz microcuvette (total volume of 120 µL) under the following conditions: 50 mM Tris (pH 
7.5 at 25 oC), 10 mM MgCl2, 1 mM EGTA, 2 mM DTT, 0.01% Brij 35 P, 10 µM Sox-PNT or 
10-250 µM Sox-peptide and 11 ng ERK2 at 30 oC. The fluorescence slopes (m) of the reactions 
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(Figure S3) were determined by a least-squares fit using Microsoft Excel, then normalized to the 
highest slope (obtained with 10 µM Sox-PNT) and plotted in the bar graph form (Figure 2a in the 
main text) for clearer visualization.  
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Figure S2. Fluorescence intensity over 10 minutes of 10 µM Sox-PNT (red) and 10-250 µM 
Sox-peptide (shades of blue) with 11 ng ERK2. 
 
d. Determination of kinetic constants for ERK2 with Sox-PNT 
 
Recombinant ERK2 (Invitrogen, 5 nM, 42 ng, MW = 69,700 g/mol) was added to initiate each 
reaction. The kinetic assays were performed in the FPR (λex = 360 nm, λem = 485 nm) in a 96-
well plate (120 µL per reaction) containing varying chemosensor concentrations (0.2–5 KM) at 30 
oC. Fluorescence slopes were determined by a least-squares fit using Microsoft Excel. Slopes 
were then converted to a rate using published procedures.1 The plots of ν vs. [S] were fit using 
SigmaPlot 9.013 in order to obtain KM and Vmax values. The assay conditions were as follows: 50 
mM Tris (pH 7.5 at 25 oC), 10 mM MgCl2, 1 mM EGTA, 2 mM DTT, 0.01% Triton X-100, 1 
mM ATP at 30 oC. Alternatively, 384-well plates can be used (20 µL reaction volume) with, 
otherwise, the same conditions. 
 
e. Selectivity of Sox-PNT in a panel of MAPKs 
 
The assays were performed in the FPR (λex = 360 nm, λem = 485 nm) in a 96-well plate (120 µL 
per reaction) containing 5 µM chemosensor at 30 oC. Recombinant ERK1 and 2, JNK1, 2, and 3, 
p38α, β, γ and δ and CDK1/Cyclin B and CDK2/Cyclin A (all enzymes were obtained from 
Invitrogen) were appropriately diluted with 50 mM Tris (pH 7.5 at 25 oC), 10 mM MgCl2, 1 mM 
ATP, 1 mM EGTA, 2 mM DTT, 0.01% Triton X-100. Addition of 15 or 150 nM of enzyme 
initiated reactions. Fluorescence slopes were determined by a least-squares fit using Microsoft 
Excel. The slopes obtained with 15 and 150 nM of enzyme were normalized to the slope with 
ERK1 and plotted on the same graph for easy visualization (Fig. 2c in the main text). Due to the 
high 150 nM concentration of enzymes, these experiments could only be performed once. The 
assays with 15 nM enzyme are reported with s.e.m. for triplicate measurements. The final assay 
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conditions were as follows: 5 µM Sox-PNT, 50 mM Tris (pH 7.5 at 25 oC), 10 mM MgCl2, 1 
mM EGTA, 2 mM DTT, 0.01% Triton X-100, 1 mM ATP and 15 or 150 nM enzyme at 30 oC.  
 
VI. Experiments in crude cell lysates 
 
a. Crude cell lysate preparation 
 
Cell cultures were maintained according to manufacturer’s recommendations using the 
appropriate media (FBS-containing solutions 17-20) that were stored at 4 oC in the dark and 
warmed to 37 oC for 30 min before use. Prior to lysis, cells were serum-starved on 150 mm tissue 
culture dishes for 15-18 h in serum-free media supplemented with an additional 2 mM L-Gln 
(Serum-free media solutions 17-20). Cells were either 1. untreated, 2. stimulated with EGF (100 
ng/mL) for 5 min at 37 oC, 3. preincubated with U0126 (5 µM delivered in 2.5 µL DMSO) for 1 
h and then stimulated with EGF (100 ng/mL) for 5 min at 37 oC, or 4. treated with DMSO (2.5 
µL) for 1 h followed by stimulation with EGF (100 ng/mL) for 5 min at 37 oC. The media was 
aspirated and cells washed with cold PBS (2 x 20 mL). The cells were kept on ice and lysed by 
addition of Lysis Buffer II (~ 100 µL/dish) directly on the plate followed by scraping and passing 
the mixture through a 22-gauge needle attached to a 1 mL syringe. The lysed solution was 
clarified at 14,000 x g for 10 min at 4 oC. The supernatant was collected and stored in aliquots at 
-80 oC. Total protein concentration was determined using Bio-Rad’s Protein Assay. 
 
b. Western blot visualization of ERK1/2 by chemiluminescence 
 
ERK1/2 expression was analyzed by western blots that were probed with anti-ERK1/2 antibody 
(Upstate) or anti-pERK1/2 antibody (Cell Signaling Tech.) according to the manufacturer’s 
protocols. Incubation with secondary antibody (goat anti-rabbit antibody conjugated to HRP 
from Pierce) was followed by exposure of the blot to SuperSignal West Dura Extended Duration 
Substrate (Pierce) and visualized by enhanced sensitivity chemiluminescence (Bio-Rad, Quantity 
One 1-D Analysis Software).  
 
c. Assays with crude cell lysates and Sox-PNT  
 
The assays were performed in the FPR (λex = 360 nm, λem = 485 nm) in a 96-well plate (120 µL 
per reaction) containing 5 µM Sox-PNT at 30 oC. Untreated, EGF-stimulated, U0126-treated 
then EGF-stimulated or DMSO-treated then EGF-stimulated lysates from NIH-3T3, HT-29, 
HeLa or PtK-1 cells were added to start the reactions. The reactions were monitored for 15 min. 
Fluorescence slopes were determined by a least-squares fit using Microsoft Excel then 
normalized to the highest slope and plotted in the bar graph form (Figure 3b in the main text and 
Figure S4) for clearer visualization. The final assay conditions were as follows: 5 µM Sox-PNT, 
50 mM Tris (pH 7.5 at 25 oC), 10 mM MgCl2, 1 mM EGTA, 2 mM DTT, 0.01% Triton X-100, 1 
mM ATP and 40 µg lysate at 30 oC. 
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Figure S4. Effects of DMSO on ERK1/2 activation. DMSO-treated and then EGF-stimulated 
lysates were assayed with Sox-PNT to show that DMSO does not have an effect on ERK1/2 
activity. This was also confirmed by western blots (inset) probed with anti-pERK1/2 (top) and 
anti-ERK1/2 (bottom) antibodies. Plotted values indicate the mean ± s.e.m. for triplicate 
measurements. 
 
d. Determination of IC50 and Ki with PEA-15 in EGF-stimulated NIH-3T3 lysates 
 
The assays were performed in the FPR (λex = 360 nm, λem = 485 nm) in a 96-well plate (120 µL 
per reaction). Sox-PNT (5 µM) was preincubated for 5 min with PEA-15 (7 concentrations in the 
0.0005-50 µM range) at 30 oC. The reactions were started by addition of EGF-stimulated NIH-
3T3 lysate and monitored for 15 min. Fluorescence slopes were determined by a least-squares fit 
using Microsoft Excel and converted to rates (ν in µM/min) using published procedures.1 The 
plots of ν vs. log [PEA-15] were fit using SigmaPlot 9.013 in order to obtain the IC50 value 
(Figure 3d in the main text). The final assay conditions were as follows: 5 µM Sox-PNT, 50 mM 
Tris (pH 7.5 at 25 oC), 10 mM MgCl2, 1 mM EGTA, 2 mM DTT, 0.01% Brij 35 P, 1 mM ATP 
and 40 µg lysate at 30 oC. 
 
The Ki value was derived from the above-determined IC50 using the following equation,4 
 
[ ]
i
M
K
K
SIC 





+= 150                  (1) 
 
where S is the concentration of Sox-PNT in the assays. Upon rearranging, eq. (1) can be solved 
for Ki.   
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e. Immunodepletions of ERK1/2 from EGF-stimulated HeLa lysate 
 
EGF-stimulated HeLa lysate (900 µg) was precleared first by incubation with Protein A 
sepharose beads (50 µL, Amersham) for 1 hr on a rotating shaker at 4 oC. The precleared EGF-
stimulated HeLa lysate (300 µg) was incubated with anti-ERK1/2 antibody (5 µg, Upstate) or 
naïve rabbit IgG (5 µg, Santa Cruz) for 1 hr on a rotating shaker at 4 oC.  The immune complexes 
were precipitated with 50 µL Protein A sepharose beads for 1 hr with mixing at 4 oC. In total, 
three rounds of immunodepletions were carried out to ensure removal of all ERK1/2. The 
immunodepletions were analyzed by western blots (probed with anti-ERK1/2 antibody from 
Upstate) that were visualized using chemilluminescence, as described above. 
 
f. Estimation of active ERK1/2 in EGF-stimulated HeLa lysates 
 
The assays were performed in the FPR (λex = 360 nm, λem = 485 nm) in a 96-well plate (120 µL 
per reaction) containing 5 µM Sox-PNT at 30 oC. The standard curve was obtained by incubating 
Sox-PNT with 0.5, 2.5 or 5 nM recombinant ERK2 and then plotting the average slope of each 
reaction as a function of ERK2 concentration (Figure S5). Using a least-squares fit in Microsoft 
Excel the following equation was obtained, 
 
47.707.45 += xy                  (2) 
 
where y is the fluorescence intensity at a given concentration of ERK2 (x) in the 0.5-2.5 nM 
range. At the same time, Sox-PNT was incubated with EGF-stimulated NIH lysates and the 
reaction slope was determined (124 min-1) by a least-squares fit using Microsoft Excel. When 
substituted in eq. (2) and solved for x, the concentration of ERK2 in EGF-stimulated NIH lysates 
is obtained (2.6 nM in 40 µg of lysate) that can also be converted to amount of enzyme (13 ng) 
because of the known reaction volume (120 µL) and ERK2 molecular weight (42,000 g/mol). 
However, since lysates contain both ERK1 and 2, the concentration (and amount) is 
representative of both enzymes. The final assay conditions were as follows: 5 µM Sox-PNT, 50 
mM Tris (pH 7.5 at 25 oC), 10 mM MgCl2, 1 mM EGTA, 2 mM DTT, 0.01% Brij 35 P, 1 mM 
ATP and 40 µg lysate, 0.5, 2.5 or 5 nM recombinant ERK2 at 30 oC. 
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Figure S5. Determination of [ERK1/2] in lysate. Standard curve with a range of ERK2 
concentrations (red circles, 0.5-5 nM) was first obtained. The standard curve was then used to 
measure the concentration (blue circle, 2.6 nM) and amount (13 ng) of ERK1/2 in 40 µg of EGF-
stimulated NIH-3T3 lysates. 
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